Lakefront Biotherapeutics NV (GLPGN) Ownership - Who Owns Lakefront Biotherapeutics NV?
Lakefront Biotherapeutics NV (GLPGN) Ownership Overview
- 3.56% Mutual Funds
- 0.07% Other Institutional Investors
- 4.20% ETFs
- 92.17% Public Companies and Individual Investors
The ownership structure of Lakefront Biotherapeutics NV (MX:GLPGN) stock is a mix of institutional, retail, and individual investors. Approximately 7.83% of the company’s stock is owned by Institutional Investors, and 92.17% is owned by Public Companies and Individual Investors.
The ownership structure of Lakefront Biotherapeutics NV (MX:GLPGN) stock is a mix of institutional, retail, and individual investors. Approximately 7.83% of the company’s stock is owned by Institutional Investors, and 92.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 11, 2026 | Henry O Gosebruch | €235,272 | |
| May 10, 2026 | Aaron Cox | €236,400 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,585,116 | Institution | 2.41% | ― |
| Ishares | 785,089 | Institution | 1.19% | ― |
| Vanguard Star Funds | 717,158 | Institution | 1.09% | ― |
| Dfa Investment Dimensions Group Inc | 625,586 | Institution | 0.95% | ― |
| Vanguard Tax-managed Funds | 483,750 | Institution | 0.73% | ― |
| Vanguard International Equity Index Funds | 353,132 | Institution | 0.54% | ― |
| Tiaa-cref Funds | 118,709 | Institution | 0.18% | ― |
| Schwab | 102,474 | Institution | 0.16% | ― |
| State Street | 74,306 | Institution | 0.11% | ― |
| Xtrackers | 73,869 | Institution | 0.11% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 717,158 | Institution | 1.09% | ― |
| Dfa Investment Dimensions Group Inc | 625,586 | Institution | 0.95% | ― |
| Vanguard Tax-managed Funds | 483,750 | Institution | 0.73% | ― |
| Vanguard International Equity Index Funds | 353,132 | Institution | 0.54% | ― |
| Tiaa-cref Funds | 118,709 | Institution | 0.18% | ― |
| Fidelity Salem Street Trust | 21,429 | Institution | 0.03% | ― |
| State Street Institutional Investment Trust | 10,952 | Institution | 0.02% | ― |
| Fidelity Concord Street Trust | 8,714 | Institution | 0.01% | ― |
| Thrivent Mutual Funds | 4,286 | Institution | <0.01% | ― |
| John Hancock Funds Ii | 1,754 | Institution | <0.01% | ― |
FAQ
What percentage of Lakefront Biotherapeutics NV (MX:GLPGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.83% of Lakefront Biotherapeutics NV (MX:GLPGN) stock is held by institutional investors: 3.56% by mutual funds, 4.20% by ETFs and 0.07% by other institutional investors.
What percentage of Lakefront Biotherapeutics NV (MX:GLPGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.17% of Lakefront Biotherapeutics NV (MX:GLPGN) stock is held by public companies and individual investors.
Who owns the most shares of Lakefront Biotherapeutics NV (MX:GLPGN)?
Vanguard owns the most shares of Lakefront Biotherapeutics NV (MX:GLPGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.